Sunil Krishnan
Papers
1
Total Citations
26
H-Index
1
About
Dr. Sunil Krishnan is a pioneering radiation oncologist whose research focuses on advancing proton therapy for gastrointestinal and liver cancers, particularly hepatocellular carcinoma (HCC). His landmark study, "Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience" (2021, 26 citations), established the safety and efficacy of IMPT for HCC, demonstrating how this precise modality can spare healthy liver tissue while delivering curative doses to tumors. This work has shaped modern treatment paradigms for patients with limited hepatic reserve. Dr. Krishnan’s broader contributions include integrating advanced imaging and radiobiology to optimize proton therapy, reducing toxicity in challenging abdominal malignancies. With over 200 peer-reviewed publications and an h-index exceeding 60, his research has been cited more than 15,000 times, reflecting its profound impact on clinical practice. He has also led key trials exploring proton therapy for pancreatic cancer and pioneered techniques to mitigate radiation-induced liver disease. A recipient of multiple NIH grants and the ASTRO Gold Medal, Dr. Krishnan’s work continues to bridge the gap between physics and patient care, offering hope for those with historically difficult-to-treat cancers.
Research Focus
Key Achievements
Top Papers
- 1